ClinicalTrials.gg
CompletedNCT03823508Updated Jul 17, 2019

Prefontal tDCS in Patients With Disorders of Consciousness: Neurophysiological and Behavioural Outcomes

An interventional study of anodal tDCS and sham tDCS in Vegetative State, Minimally Conscious State and Disorder of Consciousness, sponsored by University of Liege. Completed at 1 site in Belgium. Open to participants aged 16 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-07-17.

Sponsored by University of Liege · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jan 2018, registered Jan 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
16 Years to 75 Years
Sex
All
01

Study summary

Non-invasive brain stimulations techniques have recently shown promising results in patients with disorders. Notably, transcranial direct current stimulation (tDCS) applied over the left dorsolateral prefrontal cortex has proved to be effective in improving signs of consciousness in about 50% of patients in MCS either after a single stimulation or after repeated sessions. However, brain mechanisms underlying tDCS effects remain poorly understood. Here we aim to assess the effects of prefrontal tDCS on neurophysiological (i.e., electroencephalography - EEG - primary outcome) and behavioral (secondary outcome) measures in severely brain-injured patients with DOC.

Read the detailed description

Currently, therapeutic options for severely brain-injured patients with disorders of consciousness (DOC), including patients in unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), are limited and still need to be improved to influence long-term outcomes. Non-invasive brain stimulations (NIBS) techniques have recently shown promising results in DOC. Notably, transcranial direct current stimulation (tDCS) applied over the left dorsolateral prefrontal cortex has proved to be effective in improving signs of consciousness in about 50% of patients in MCS either after a single stimulation or after repeated sessions. However, brain mechanisms underlying tDCS effects remain poorly understood.In the present protocol, the investigators will assess the effects of prefrontal tDCS on neurophysiological (i.e., electroencephalography - EEG - primary outcome) and behavioral (secondary outcome) measures in severely brain-injured patients with DOC in a double-blind sham-controlled design. One anodal and one sham tDCS will be delivered in a randomized order in chronic (>28 days post-onset) severely brain-damaged patients. The stimulation will have an intensity of 2 mA and will last 20 minutes. The anode will be placed on the left dorsolateral prefrontal cortex and the cathode on the right supraorbital region. Ten minutes of high-density EEG will be recorded using a 256-channel saline electrode net (Electrical Geodesics) directly before and after each tDCS session. Behavioral assessments will be performed using the Coma Recovery Scale-Revised before and after each session by an investigator blinded to the treatment allocation.

02

Conditions studied

  • Vegetative State
  • Minimally Conscious State
  • Disorder of Consciousness

Keywords

  • Vegetative state
  • Minimally Conscious State
  • Disorders of consciousness
  • Transcranial direct current stimulation
  • Non invasive brain stimulation
  • Neuromodulation
  • High density electroencephalography
03

In context

Persistent Vegetative State

88 studies on the registry are indexed under Persistent Vegetative State; 20 are open to participants now.

This study's enrollment of 15 is below the median of 30 across 55 interventional studies indexed under Persistent Vegetative State.

Browse Persistent Vegetative State studies →

Lead sponsor

University of Liege is the lead sponsor of 251 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • post-comatose patients
  • patients in vegetative state/unresponsive wakefulness syndrome or in minimally conscious state
  • patients with stable condition
  • patients free of sedative drugs and Na+ or Ca++ blockers (e.g., carbamazepine) or NMDA receptor antagonist (e.g., dextromethorphan)

Exclusion criteria

Exclusion Criteria:

  • premorbid neurology antecedent
  • patients in coma
  • patients \< 28 days after the acute brain injury
  • patients with a metallic cerebral implant/a shunt
  • cranioplasty
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
15 participants (actual)

Study arms

  • Active comparator
    anodal tDCS

    Patients will receive anodal tDCS (left dorsolateral prefrontal stimulation) during 20 minutes preceded and followed by a clinical assessment (Coma Recovery Scale-Revised) and neurophysiological assessment (256 channels EEG).

    Device: anodal tDCS

  • Placebo comparator
    sham tDCS

    Patients will receive sham tDCS (15 secondes of stimulation) during 20 minutes preceded and followed by a clinical assessment (Coma Recovery Scale-Revised) and neurophysiological assessment (256 channels EEG).

    Device: sham tDCS

Interventions

  • Deviceanodal tDCS

    Patients will receive anodal tDCS during 20 minutes preceded and followed by a behavioral assessment (Coma Recovery Scale Revised) and a high density EEG. The anode will be placed over F3 in order to stimulate the left dorsolateral prefrontal cortex and the cathode over the right supraorbital area.

  • Devicesham tDCS

    Identical to anodal tDCS, except that the stimulation will be stopped after 15 seconds.

06

What researchers measure

Primary outcomes

  1. Change in the CRS-R scores

    CRS-R will be performed before and after tDCS (anodal and sham). Comparison of the treatment effect (CRS-R total score after tDCS minus before) between real and sham tDCS

    Time frame: Baseline and directly after the tDCS (20 minutes)

Secondary outcomes

  1. Change in EEG

    256 channels EEG will be record before and after tDCS to record potential cortical changes induce by the stimulation.

    Time frame: Baseline and directly after the tDCS (20 minutes)

  2. Change in the vigilance level

    Ocular parameters will be record using glasses before and after tDCS to record potential change of the vigilance level

    Time frame: Baseline and directly after the tDCS (20 minutes)

07

Study locations

1 site
  • University Hospital of Liege
    Liege, 4000, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03823508
Responsible party
Aurore Thibaut (Principal Investigator, University of Liege) — Principal investigator
First posted
Jan 30, 2019
Start date
Jan 1, 2018
Primary completion
Jun 1, 2019
Completion
Jun 1, 2019
Last update
Jul 17, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion